Sumitomo Mitsui DS Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-7,251	Closed	-$326K	–	770
2021 Q1	$326K	Hold	7,251	–	–	0.01%	694
2020 Q4	$409K	Hold	7,251	–	–	0.01%	653
2020 Q3	$344K	Hold	7,251	–	–	0.01%	640
2020 Q2	$427K	Buy	7,251 +15	+0.2%	+$834	0.01%	588
2020 Q1	$342K	Buy	7,236 +54	+0.8%	+$3.01K	0.01%	575
2019 Q4	$433K	Hold	7,182	–	–	0.01%	619
2019 Q3	$430K	Buy	7,182 +1,099	+18%	+$71.6K	0.02%	587
2019 Q2	$390K	Buy	+6,083	New	+$430K	0.02%	597
2016 Q2	–	Sell	-8,290	Closed	-$335K	–	717
2016 Q1	$335K	Buy	8,290 +116	+1%	+$4.71K	0.01%	660
2015 Q4	$506K	Buy	8,174 +50	+0.6%	+$2.7K	0.02%	582
2015 Q3	$328K	Hold	8,124	–	–	0.01%	662
2015 Q2	$467K	Sell	8,124 -154	-2%	-$9.79K	0.01%	647
2015 Q1	$527K	Buy	+8,278	New	+$562K	0.02%	620

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Sumitomo Mitsui DS Asset Management's IONS Position: Q2 2021 in Review

Sumitomo Mitsui DS Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q2 2021, closing a stake of 7,251 shares — an estimated $326K sold.

Sumitomo Mitsui DS Asset Management first reported a position in IONS in Q1 2015 and held it in 13 quarters. The position peaked at $527K in Q1 2015. 338 funds tracked by Wall St. Rank hold IONS as of Q2 2021.

Sumitomo Mitsui DS Asset Management reported no remaining Ionis Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Sumitomo Mitsui DS Asset Management sold 7,251 Ionis Pharmaceuticals shares in Q2 2021, an estimated $326K.
Sumitomo Mitsui DS Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2015 and held it in 13 quarters.
Sumitomo Mitsui DS Asset Management's Ionis Pharmaceuticals position peaked at $527K in Q1 2015.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2021.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2021, filed 19 Jul 2021.